Objective: To investigate 26S proteasome non-ATPase regulatory subunit 13 (PSMD13) gene silencing as a potential treatment for neuroinflammatory disorders via regulation of microglial activation and production of inflammatory mediators.
Methods: RNA interference was used to knockdown PSMD13 gene expression, followed by inhibitors of κB (IκBα) protein degradation and nuclear factor κB (NF-κB) activity measurement in lipopolysaccharide (LPS)-stimulated BV2 microglia. Nitrite (Griess) assay, reporter gene assay, enzyme-linked immunosorbent assay and Western blot were used to investigate the role of PSMD13 in microglial activation and inflammation.
Results: PSMD13 gene knockdown significantly reduced IκBα degradation and NF-κB activation in LPS-stimulated murine BV2 microglia. It also decreased the production of LPS-induced proinflammatory mediators, such as inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and prostaglandin E2.
Conclusions: PSMD13 gene silencing suppressed the production of proinflammatory mediators by modulating ubiquitin-proteasome system-mediated neuroinflammation via the downregulation of IκBα degradation and NF-κB activation in LPS-stimulated BV2 microglia. PSMD13 gene knockdown may have therapeutic implications for the treatment of neuroinflammatory disorders.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000357811 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comprehensive analysis reveals the prognostic and immunological role of PSMD13 in hepatocellular carcinoma.
Mamm Genome
December 2024
Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
Immune cell infiltration in liver hepatocellular carcinoma (LIHC) is promising for immunotherapy. However, effective predictive markers to accurately predict a tumour's immune status are lacking. PSMD13, a native component of the 26 S proteasome subunit involved in intracellular metabolism, has an unclear association with cancer and immunity.
View Article and Find Full Text PDFIdentification and validation of a novel five-gene signature in high-risk MYCN-not-amplified neuroblastoma.
Discov Oncol
September 2024
Clinical Research Unit, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200062, China.
Article Synopsis
- High-risk neuroblastoma patients, particularly those who are MYCN-not-amplified, often face poor survival outcomes, prompting a study aimed at developing a gene signature for better risk stratification.
- Researchers analyzed microarrays and RNA sequencing data, identifying a unique set of five prognostic-related genes (GAL, GFRA3, MARCKS, PSMD13, and ZNHIT3) that effectively categorized patients into ultra-high and high-risk groups.
- The study's findings indicate that this gene signature can significantly predict overall survival rates, making it a valuable tool for personalizing treatment strategies in HR-MYCN-NA neuroblastoma patients.
Appraising non-linear association between pre-diagnostic platelet counts and cancer survival outcomes: observational and genetic analysis.
Platelets
December 2024
Department of laboratory medicine, West China Hospital, Sichuan University, Chengdu, China.
Previous studies have reported inconsistent associations between platelet count (PLT) and cancer survival. However, whether there is linear causal effect merits in-depth investigations. We conducted a cohort study using the UK Biobank and a two-sample Mendelian randomization (MR) analysis.
View Article and Find Full Text PDFThe Expansion of Sirtuin Gene Family in Gilthead Sea Bream ()-Phylogenetic, Syntenic, and Functional Insights across the Vertebrate/Fish Lineage.
Int J Mol Sci
June 2024
Instituto de Acuicultura Torre de la Sal (IATS, CSIC), 12595 Ribera de Cabanes, Castellón, Spain.
The Sirtuin (SIRT1-7) family comprises seven evolutionary-conserved enzymes that couple cellular NAD availability with health, nutrition and welfare status in vertebrates. This study re-annotated the sirt3/5 branch in the gilthead sea bream, revealing three paralogues of (//) and two of (/) in this Perciform fish. The phylogeny and synteny analyses unveiled that the Sirt3.
View Article and Find Full Text PDFAn Analysis Regarding the Association Between Proteasome (PSM) and Hepatocellular Carcinoma (HCC).
J Hepatocell Carcinoma
March 2023
Department of Oncology, Nanjing Jinling Hospital, Nanjing, Jiangsu, 210001, People's Republic of China.
Background: The Proteasome (PSM) is a large multi-catalytic protease complex consisting of a 20S core particle and a 19S regulatory particle whose main function is to accept and degrade ubiquitinated substrates, are now considered as one of the potential regulators of tumor proliferation, and stemness maintenance. However, to date, studies on the relationship between PSM and hepatocellular carcinoma (HCC) are limited.
Methods: This study used a bioinformatics approach combining validation experiments to investigate the biological mechanisms that may be related with PSM.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!